Löffler's endomyocarditis in the idiopathic hypereosinophilic syndrome.
The idiopathic hypereosinophilic syndrome (HES) is a leukoproliferative disorder characterized by sustained eosinophilia (> 1.5 x 10(9)/l) and (multi-)organ dysfunction caused by infiltration of eosinophils. Especially the heart is frequently affected. In this report, we describe 2 patients with HES and Löffler's endomyocarditis. Prednisone is the drug of choice for treatment. Both our patients responded very well to prednisone and came into remission. If prednisone fails, there are other therapeutic options like myelosuppressive drugs (hydroxyurea and vincristine) or interferon-alpha. We review the literature with regard to clinical presentation, diagnosis and treatment.
Corssmit
E P
EP
Department of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands. E.P.Corssmit@amc.uva.nl
Trip
M D
MD
Durrer
J D
JD
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D015150:Echocardiography, Doppler; D004562:Electrocardiography; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000175:diagnosis* / Q000188:drug therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D009205:Myocarditis / Q000175:diagnosis* / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D011657:Pulmonary Eosinophilia / Q000175:diagnosis / Q000188:drug therapy; D012074:Remission Induction
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D011241:Prednisone